Fla. Federal Belviq Breast Cancer Action Survives Dismissal Motion



DOCUMENTS
  • Order


OCALA, Fla. — A Florida federal judge has refused to dismiss an action in which a woman alleges Belviq caused her breast cancer, ruling she adequately pled the weight loss drug was unreasonably dangerous because its active ingredient had a propensity to cause cancer.

However, in the Dec. 14 order, Judge Anne C. Conway of the U.S. District Court for the Middle District of Florida dismissed the plaintiff’s claim for fraudulent misrepresentation, finding plaintiff failed to adequately allege how she or her doctor’s decisions were affected by defendants’ advertisements.

Before seeking FDA approval for Belviq, defendants Eisai Inc. and Arena …

FIRM NAMES
  • Arnold & Porter Kaye Scholer LLP
  • Beasley Allen Crow Methvin Portis & Miles PC
  • Carlton Fields PA
  • Shook Hardy & Bacon LLP
  • Sidley Austin





UPCOMING CONFERENCES




HarrisMartin's Pesticide Litigation Conference: A Plaintiff's Approach to Winning Pesticide Cases

June 16, 2022 - Denver, CO
Plaintiff-Only Event @ The Westin Denver Downtown

MORE DETAILS



HarrisMartin's MDL Conference: Recalled Infant Formula and Gardasil

May 25, 2022 - Pittsburgh, PA
The Omni William Penn Hotel

MORE DETAILS